Daniel Douglas von Hoff

Daniel Douglas von Hoff

Fondateur chez Cylene Pharmaceuticals, Inc.

76 ans
Consumer Services
Health Technology
Health Services

Profil

Daniel Douglas Von Hoff is the founder of Medelis, Inc. (founded in 2003) and Cylene Pharmaceuticals, Inc. (founded in 1997).
At Cylene Pharmaceuticals, Inc., he holds the title of Director & Vice President-Medical Affairs starting in 2010.
Dr. Von Hoff is also the founder of ILEX Oncology, Inc., Investigational New Drugs.
Von Hoff's current job(s) include Executive Director-Tissue Banking & Analysis at Caris Molecular Profiling Institute, Inc., Director & Chief Clinical Strategist at Systems Oncology LLC, Professor at the University of Arizona, Physician at Scottsdale Healthcare Corp., Professor at Translational Genomics Research Institute, Professor at Texas University of Health Center at San Antonio, and Principal at TVP Management Co. LLC.
Von Hoff's former job(s) include Independent Director at Genta, Inc. (2011-2012), Director-Scientific Development at INSYS Therapeutics, Inc., Director-Drug Development at Cancer Therapy & Research Center Foundation, Senior Vice President-Medical Affairs at Aptose Biosciences, Inc., Chief Scientific Officer at US Oncology, Inc., Professor at The University of Texas at Austin, Principal at the University of California, Berkeley, Professor at The Mayo Clinic (Old), Professor at Mayo Foundation for Medical Education & Research, Member at American Society of Clinical Oncology, Inc., and President at American Association for Cancer Research.
Von Hoff's education history includes a doctorate degree from The Trustees of Columbia University in The City of New York, an undergraduate degree from Carroll College (Montana), and an undergraduate degree from Columbia University College of Physicians & Surgeons.

Postes actifs de Daniel Douglas von Hoff

SociétésPosteDébut
Corporate Officer/Principal -
Fondateur 01/01/1997
Corporate Officer/Principal -
Private Equity Investor 04/03/2010
University of Arizona Corporate Officer/Principal 25/07/2011
Directeur Technique/Scientifique/R&D -
Texas University of Health Center at San Antonio Corporate Officer/Principal -
Directeur/Membre du Conseil -
Tous les postes actifs de Daniel Douglas von Hoff

Anciens postes connus de Daniel Douglas von Hoff

SociétésPosteFin
Directeur/Membre du Conseil 24/04/2012
░░░░░░░░ ░░░░ ░░░░░░░░░ -
░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░ ░░░░ ░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
Voir l'expérience en détail de Daniel Douglas von Hoff

Formation de Daniel Douglas von Hoff

The Trustees of Columbia University in The City of New York Doctorate Degree
Carroll College (Montana) Undergraduate Degree
Columbia University College of Physicians & Surgeons Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Daniel Douglas von Hoff

Relations

100 +

Relations au 1er degré

25

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
APTOSE BIOSCIENCES INC.

Health Technology

Entreprise privées17

Health Technology

Commercial Services

Health Services

Health Services

Health Technology

Health Services

Finance

Commercial Services

Health Technology

Investigational New Drugs

Health Technology

Commercial Services

Health Services

Health Services

Cancer Therapy & Research Center Foundation

Commercial Services

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Daniel Douglas von Hoff